HCWB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HCWB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
HCW Biologics's Change In Other Working Capital for the quarter that ended in Mar. 2024 was $-0.06 Mil. It means HCW Biologics's Other Working Capital declined by $0.06 Mil from Dec. 2023 to Mar. 2024 .
HCW Biologics's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-0.33 Mil. It means HCW Biologics's Other Working Capital declined by $0.33 Mil from Dec. 2022 to Dec. 2023 .
The historical data trend for HCW Biologics's Change In Other Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCW Biologics Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Change In Other Working Capital | - | - | - | -0.13 | -0.33 |
HCW Biologics Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Change In Other Working Capital | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.08 | -0.08 | -0.08 | -0.08 | -0.06 |
Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.
Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of HCW Biologics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.
Gary M Winer | director | C/O LENSAR, INC., 2800 DISCOVERY DRIVE, ORLANDO FL 32826 |
Hing C Wong | director, officer: Chief Executive Officer | C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025 |
Rebecca Byam | officer: Chief Financial Officer | C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025 |
Lee Flowers | officer: SVP of Business Development | C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025 |
Rick S. Greene | director | C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025 |
Jin-an Jiao | officer: VP of Development | C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025 |
Lisa M. Giles | director | DURATA THERAPEUTICS, INC., 200 SOUTH WACKER DRIVE SUITE 2550, CHICAGO IL 60606 |
Scott T Garrett | director | 35 CROSBY DRIVE, BEDFORD MA 01730 |
Peter Rhode | officer: See Remarks | C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025 |
Medmira Capital Ltd. | 10 percent owner | 16F BEIKE BUILDING, 59 GAOXIN NANJIU RD, SHENZHEN F4 518057 |
From GuruFocus
By PurpleRose PurpleRose • 07-12-2022
By Marketwired • 09-06-2023
By sperokesalga sperokesalga • 04-13-2023
By Value_Insider Value_Insider • 12-07-2022
By GuruFocus Research • 05-26-2023
By GuruFocus Research • 09-16-2023
By GuruFocusNews GuruFocusNews • 06-22-2022
By sperokesalga sperokesalga • 06-14-2023
By GuruFocusNews GuruFocusNews • 06-02-2022
By PurpleRose PurpleRose • 07-12-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.